Literature DB >> 20563703

Hybrid cells differentiate to hepatic lineage cells and repair oxidative damage.

Dan Xu1, Feng Wang, Hongyan Gu, Jia Wang, Qinglong Guo, Yanli Zhang, Ziyu Wang.   

Abstract

Hybrid cells derived from stem cells play an important role in organogenesis, tissue regeneration and cancer formation. However, the fate of hybrid cells and their range of function are poorly understood. Fusing stem cells and somatic cells induces somatic cell reprogramming, and the resulting hybrid cells are embryonic stem cell-like cells. Therefore, we hypothesize that fusion-induced hybrid cells may behave like ES cells in certain microenvironments. In this study, human hepatic cells were induced to apoptosis with H(2)O(2), and then co-cultured with hybrid cells that had been derived from mouse ES cells and human hepatic cells using a transwell. After co-culturing, the degree of apoptosis was evaluated using Annexin-V/PI double-staining analysis, flow cytometry and Western-blot. We observed that H(2)O(2)-induced cell apoptosis was inhibited by co-culture. In addition, the activity of injury-related enzymes (GSH-Px, LDH and SOD) and the level of albumin release in the co-culture system trended toward the level of normal undamaged hepatic cells. The stably increased levels of secretion of ALB in the co-culture system also confirmed that co-culture with hybrid cells helped in recovery from injury. The fate of the hybrid cells was studied by analyzing their gene expression and protein expression profiles. The results of RT-PCR indicated that during co-culturing, like ES cells, hybrid cells differentiated into hepatic lineage cells. Hybrid cells transcripted genes from both parental cell genomes. Via immunocytochemical analysis, hepatic directional differentiation of the hybrid cells was also confirmed. After injecting the hybrid cells into the mouse liver, the GFP-labeled transplanted cells were distributed in the hepatic lobules and engrafted into the liver structure. This research expands the knowledge of fusion-related events and the possible function of hybrid cells. Moreover, it could indicate a new route of differentiation from pluripotent cells to tissue-specific cells via conditional co-culture.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20563703      PMCID: PMC6275737          DOI: 10.2478/s11658-010-0018-0

Source DB:  PubMed          Journal:  Cell Mol Biol Lett        ISSN: 1425-8153            Impact factor:   5.787


Supplementary material, approximately 16.6 MB.
  51 in total

1.  Stem cells: Fusion brings down barriers.

Authors:  Alexander Medvinsky; Austin Smith
Journal:  Nature       Date:  2003-04-24       Impact factor: 49.962

2.  Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes.

Authors:  Manuel Alvarez-Dolado; Ricardo Pardal; Jose M Garcia-Verdugo; John R Fike; Hyun O Lee; Klaus Pfeffer; Carlos Lois; Sean J Morrison; Arturo Alvarez-Buylla
Journal:  Nature       Date:  2003-10-12       Impact factor: 49.962

Review 3.  Stem cell therapy of the liver--fusion or fiction?

Authors:  Marc H Dahlke; Felix C Popp; Stephen Larsen; Hans J Schlitt; John E J Rasko
Journal:  Liver Transpl       Date:  2004-04       Impact factor: 5.799

4.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

5.  Human cord blood CD34+ cells develop into hepatocytes in the livers of NOD/SCID/gamma(c)null mice through cell fusion.

Authors:  Hisanori Fujino; Hidefumi Hiramatsu; Atsunori Tsuchiya; Akira Niwa; Haruyoshi Noma; Mitsutaka Shiota; Katsutsugu Umeda; Momoko Yoshimoto; Mamoru Ito; Toshio Heike; Tatsutoshi Nakahata
Journal:  FASEB J       Date:  2007-06-18       Impact factor: 5.191

6.  Co-culture of human CD34+ cells with mesenchymal stem cells increases the survival of CD34+ cells against the 5-aza-deoxycytidine- or trichostatin A-induced cell death.

Authors:  Sang Hyeok Koh; Hyoung Soo Choi; Eun Sil Park; Hyoung Jin Kang; Hyo Seop Ahn; Hee Young Shin
Journal:  Biochem Biophys Res Commun       Date:  2005-04-15       Impact factor: 3.575

7.  Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin.

Authors:  Jacob Hanna; Marius Wernig; Styliani Markoulaki; Chiao-Wang Sun; Alexander Meissner; John P Cassady; Caroline Beard; Tobias Brambrink; Li-Chen Wu; Tim M Townes; Rudolf Jaenisch
Journal:  Science       Date:  2007-12-06       Impact factor: 47.728

8.  In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.

Authors:  Marius Wernig; Alexander Meissner; Ruth Foreman; Tobias Brambrink; Manching Ku; Konrad Hochedlinger; Bradley E Bernstein; Rudolf Jaenisch
Journal:  Nature       Date:  2007-06-06       Impact factor: 49.962

9.  Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.

Authors:  Masato Nakagawa; Michiyo Koyanagi; Koji Tanabe; Kazutoshi Takahashi; Tomoko Ichisaka; Takashi Aoi; Keisuke Okita; Yuji Mochiduki; Nanako Takizawa; Shinya Yamanaka
Journal:  Nat Biotechnol       Date:  2007-11-30       Impact factor: 54.908

10.  Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle.

Authors:  A J Gibson; J Karasinski; J Relvas; J Moss; T G Sherratt; P N Strong; D J Watt
Journal:  J Cell Sci       Date:  1995-01       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.